+++
name = "WWL113U"
target = "CES3 (Ces1d)"
activity = "Control compound for <a href='#wwl113' class='js-scroll-trigger'>WWL113</a>"
pubchem_cid = "72183489"
cas = "1528560-36-2"
systematic_name = "ethyl 4'-(3-methyl-3-(3-(pyridin-4-yl)benzyl)ureido)-[1,1'-biphenyl]-4-carboxylate"
synonyms = []
molecular_weight = "465.21"


[[references]]
authors_list = "Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K. L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E."
title = "Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes"
journal = "Nat. Chem. Biol."
year = 2014
volume = 10
pages = "113-121"
doi_link = "https://doi.org/10.1038/nchembio.1429"
pubmed_link = "https://www.ncbi.nlm.nih.gov/pubmed/24362705"

+++

WWL113U is a structurally related control compound for <a href="#wwl113" class="js-scroll-trigger">WWL113</a>. Substitution of the carbamate group with a urea group renders WWL113U unable to inhibit Ces3 or Ces1f. WWL113U does not promote differentiation of preadipocytes or inhibit basal lipolysis in mature adipocytes. It also does not inhibit human CES1, the homolog of mouse Ces3.